AIM: Few interventions address social cognition or functioning in individuals at clinical risk (CR) for psychosis. Theatre Improvisation Training to Promote Social Cognition (TIPS) is a manualized intervention based on drama therapy. We aim to describe TIPS, evaluate feasibility and acceptability, and present a preliminary investigation of outcomes in a quasi-experimental design. METHODS: Thirty-six CR participants (15-25 years) were ascertained from the Philadelphia Neurodevelopmental Cohort. Twenty-six completed the TIPS protocol: 18 weekly 2-hour group sessions led by a theatre director and actor-assistant. Participants engaged in collaborative acting and improvisation exercises. Baseline and follow-up assessments included the Clinical Assessment Interview for Negative Symptoms (CAINS), Structured Interview for Prodromal Syndromes, Global Assessment of Functioning (GAF) and Penn Computerized Neurocognitive Battery (CNB), which includes social cognitive tests. Acceptability was assessed using focus groups. Preliminary outcomes were compared to CR controls who were not enrolled in the study but completed follow-up assessments using the same methods. RESULTS: There were no significant differences in baseline demographics, psychosis symptoms, or cognition between those who did and did not complete the protocol. Overall, TIPS was considered feasible and acceptable among CR. Preliminary outcomes suggest that TIPS may be effective in improving positive and negative psychosis-spectrum symptoms and GAF, but not performance on facial emotion processing. CONCLUSIONS: TIPS is a promising and acceptable intervention that may improve symptoms and functioning in CR while providing a framework for participants to develop more empowered and confident ways of relating to others. Larger randomized controlled trials investigating TIPS efficacy are warranted.
AIM: Few interventions address social cognition or functioning in individuals at clinical risk (CR) for psychosis. Theatre Improvisation Training to Promote Social Cognition (TIPS) is a manualized intervention based on drama therapy. We aim to describe TIPS, evaluate feasibility and acceptability, and present a preliminary investigation of outcomes in a quasi-experimental design. METHODS: Thirty-six CR participants (15-25 years) were ascertained from the Philadelphia Neurodevelopmental Cohort. Twenty-six completed the TIPS protocol: 18 weekly 2-hour group sessions led by a theatre director and actor-assistant. Participants engaged in collaborative acting and improvisation exercises. Baseline and follow-up assessments included the Clinical Assessment Interview for Negative Symptoms (CAINS), Structured Interview for Prodromal Syndromes, Global Assessment of Functioning (GAF) and Penn Computerized Neurocognitive Battery (CNB), which includes social cognitive tests. Acceptability was assessed using focus groups. Preliminary outcomes were compared to CR controls who were not enrolled in the study but completed follow-up assessments using the same methods. RESULTS: There were no significant differences in baseline demographics, psychosis symptoms, or cognition between those who did and did not complete the protocol. Overall, TIPS was considered feasible and acceptable among CR. Preliminary outcomes suggest that TIPS may be effective in improving positive and negative psychosis-spectrum symptoms and GAF, but not performance on facial emotion processing. CONCLUSIONS:TIPS is a promising and acceptable intervention that may improve symptoms and functioning in CR while providing a framework for participants to develop more empowered and confident ways of relating to others. Larger randomized controlled trials investigating TIPS efficacy are warranted.
Authors: Tandy J Miller; Thomas H McGlashan; Joanna L Rosen; Kristen Cadenhead; Tyrone Cannon; Joseph Ventura; William McFarlane; Diana O Perkins; Godfrey D Pearlson; Scott W Woods Journal: Schizophr Bull Date: 2003 Impact factor: 9.306
Authors: Monica E Calkins; Tyler M Moore; Kathleen R Merikangas; Marcy Burstein; Theodore D Satterthwaite; Warren B Bilker; Kosha Ruparel; Rosetta Chiavacci; Daniel H Wolf; Frank Mentch; Haijun Qiu; John J Connolly; Patrick A Sleiman; Hakon Hakonarson; Ruben C Gur; Raquel E Gur Journal: World Psychiatry Date: 2014-10 Impact factor: 49.548
Authors: William P Horan; Michael F Green; Michael DeGroot; Alan Fiske; Gerhard Hellemann; Kimmy Kee; Robert S Kern; Junghee Lee; Mark J Sergi; Kenneth L Subotnik; Catherine A Sugar; Joseph Ventura; Keith H Nuechterlein Journal: Schizophr Bull Date: 2011-03-07 Impact factor: 9.306
Authors: Monica E Calkins; Tyler M Moore; Theodore D Satterthwaite; Daniel H Wolf; Bruce I Turetsky; David R Roalf; Kathleen R Merikangas; Kosha Ruparel; Christian G Kohler; Ruben C Gur; Raquel E Gur Journal: World Psychiatry Date: 2017-02 Impact factor: 49.548
Authors: Michael F Green; David L Penn; Richard Bentall; William T Carpenter; Wolfgang Gaebel; Ruben C Gur; Ann M Kring; Sohee Park; Steven M Silverstein; Robert Heinssen Journal: Schizophr Bull Date: 2008-01-08 Impact factor: 9.306
Authors: Sunny X Tang; Lindsay D Oliver; Katrin Hänsel; Pamela DeRosse; Majnu John; Ammar Khairullah; James M Gold; Robert W Buchanan; Aristotle Voineskos; Anil K Malhotra Journal: Transl Psychiatry Date: 2022-06-06 Impact factor: 7.989
Authors: Lee A Lindquist; Anna Liggett; Ruqayyah Muhammad; Anne Seltzer; Kwang-Youn A Kim; Becca Barish; Abby Wagner; Vanessa Ramirez-Zohfeld Journal: Gerontol Geriatr Med Date: 2021-05-25
Authors: J Cobb Scott; Tyler M Moore; Dan J Stein; Adele Pretorius; Zukiswa Zingela; Mohammed Nagdee; Linda Ngqengelele; Megan Campbell; Goodman Sibeko; Mary Claire King; Jon M McClellan; Allison M Port; Chad Jackson; Kosha Ruparel; Ezra S Susser; Ruben C Gur Journal: Neuropsychology Date: 2021-07-05 Impact factor: 3.424
Authors: David M Lydon-Staley; Eli J Cornblath; Ann Sizemore Blevins; Danielle S Bassett Journal: Neuropsychopharmacology Date: 2020-08-28 Impact factor: 8.294